A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC

NCT07062328 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Carcinoma

Interventions

DRUG: Recaticimab and Adebrelimab
DRUG: GP chemotherapy

Sponsor

Sun Yat-sen University

Collaborators

[object Object]